These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 37848754)

  • 21. Antipsychotic Adherence and Rehospitalization in Schizophrenia Patients Receiving Oral Versus Long-Acting Injectable Antipsychotics Following Hospital Discharge.
    Marcus SC; Zummo J; Pettit AR; Stoddard J; Doshi JA
    J Manag Care Spec Pharm; 2015 Sep; 21(9):754-68. PubMed ID: 26308223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipid based intramuscular long-acting injectables: Current state of the art.
    Wilkinson J; Ajulo D; Tamburrini V; Gall GL; Kimpe K; Holm R; Belton P; Qi S
    Eur J Pharm Sci; 2022 Nov; 178():106253. PubMed ID: 35793750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors Associated with the Initiation of Long-Acting Injectable Paliperidone Palmitate Versus Aripiprazole Among Medicaid Patients with Schizophrenia: An Observational Study.
    Cai Q; Patel C; Kim E; Connolly N; Tunceli O; El Khoury AC
    Adv Ther; 2019 Apr; 36(4):858-869. PubMed ID: 30848442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of age and CYP2D6 genotype on exposure of zuclopenthixol in patients using long-acting injectable versus oral formulation-an observational study including 2044 patients.
    Tveito M; Smith RL; Molden E; Høiseth G
    Eur J Clin Pharmacol; 2021 Feb; 77(2):215-221. PubMed ID: 33000414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Accelerated and Biopredictive In Vitro Release Testing Strategy for Single Agent and Combination Long-Acting Injectables.
    Jain KMH; Ho T; Hoe S; Wan B; Muthal A; Subramanian R; Foti C
    J Pharm Sci; 2024 Jul; 113(7):1885-1897. PubMed ID: 38369022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Baseline results from the European non-interventional Antipsychotic Long acTing injection in schizOphrenia (ALTO) study.
    Llorca PM; Bobes J; Fleischhacker WW; Heres S; Moore N; Bent-Ennakhil N; Sapin C; Loze JY; Nylander AG; Patel MX
    Eur Psychiatry; 2018 Aug; 52():85-94. PubMed ID: 29734130
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Continuation of schizophrenia treatment with three long-acting injectable antipsychotics in South Korea: A nationwide population-based study.
    Joo SW; Shon SH; Choi G; Koh M; Cho SW; Lee J
    Eur Neuropsychopharmacol; 2019 Sep; 29(9):1051-1060. PubMed ID: 31362852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Concurrent Oral Antipsychotic Drug Use Among Schizophrenia Patients Initiated on Long-Acting Injectable Antipsychotics Post-Hospital Discharge.
    Doshi JA; Pettit AR; Stoddard JJ; Zummo J; Marcus SC
    J Clin Psychopharmacol; 2015 Aug; 35(4):442-6. PubMed ID: 26075492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simulated long-term outcomes of early use of long-acting injectable antipsychotics in early schizophrenia.
    Horvitz-Lennon M; Predmore Z; Orr P; Hanson M; Hillestad R; Durkin M; Kim E; Mattke S
    Early Interv Psychiatry; 2019 Dec; 13(6):1357-1365. PubMed ID: 30548103
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment discontinuation of long-acting injectables or oral atypical antipsychotics among Medicaid recipients with schizophrenia.
    Song X; El Khoury AC; Brouillette M; Smith D; Joshi K
    J Med Econ; 2019 Nov; 22(11):1105-1112. PubMed ID: 31062998
    [No Abstract]   [Full Text] [Related]  

  • 31. Attitudes of European physicians towards the use of long-acting injectable antipsychotics.
    Patel MX; Bent-Ennakhil N; Sapin C; di Nicola S; Loze JY; Nylander AG; Heres S
    BMC Psychiatry; 2020 Mar; 20(1):123. PubMed ID: 32169077
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patient and prescriber perspectives on long-acting injectable (LAI) antipsychotics and analysis of in-office discussion regarding LAI treatment for schizophrenia.
    Potkin S; Bera R; Zubek D; Lau G
    BMC Psychiatry; 2013 Oct; 13():261. PubMed ID: 24131801
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of SGA oral medications and a long-acting injectable SGA: the PROACTIVE study.
    Buckley PF; Schooler NR; Goff DC; Hsiao J; Kopelowicz A; Lauriello J; Manschreck T; Mendelowitz AJ; Miller del D; Severe JB; Wilson DR; Ames D; Bustillo J; Mintz J; Kane JM;
    Schizophr Bull; 2015 Mar; 41(2):449-59. PubMed ID: 24870446
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A single assessment with the Brief Adherence Rating Scale (BARS) discriminates responders to long-acting injectable antipsychotic treatment in patients with schizophrenia.
    Nakonezny PA; Lindow JC; Stroup TS; McEvoy JP; Swartz MS; Rosenheck RA; Byerly MJ
    Schizophr Res; 2020 Jun; 220():92-97. PubMed ID: 32269005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic Drug Monitoring of Long-Acting Injectable Antipsychotic Drugs.
    Schoretsanitis G; Baumann P; Conca A; Dietmaier O; Giupponi G; Gründer G; Hahn M; Hart X; Havemann-Reinecke U; Hefner G; Kuzin M; Mössner R; Piacentino D; Steimer W; Zernig G; Hiemke C
    Ther Drug Monit; 2021 Feb; 43(1):79-102. PubMed ID: 33196621
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparative study of paliperidone palmitate and risperidone long-acting injectable therapy in schizophrenia.
    Li H; Rui Q; Ning X; Xu H; Gu N
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):1002-8. PubMed ID: 21315787
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Real-World Evidence of the Clinical and Economic Impact of Long-Acting Injectable Versus Oral Antipsychotics Among Patients with Schizophrenia in the United States: A Systematic Review and Meta-Analysis.
    Lin D; Thompson-Leduc P; Ghelerter I; Nguyen H; Lafeuille MH; Benson C; Mavros P; Lefebvre P
    CNS Drugs; 2021 May; 35(5):469-481. PubMed ID: 33909272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of discontinuation and hospitalization during long-acting injectable antipsychotic treatment in patients with schizophrenia spectrum disorder.
    Üçok A; Yağcioğlu EA; Aydin M; Kara İA; Erbasan V; Türkoğlu Ö; Ergün S; Chousein MG; Oktar N; Uçar N; Köroğlu BS; Ozan E
    Int Clin Psychopharmacol; 2021 Mar; 36(2):89-96. PubMed ID: 33512962
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Focused Ethnographic Examination of Barriers to Use of Long-Acting Injectable Antipsychotics.
    Robinson DG; Subramaniam A; Fearis PJ; Shi R; Walsh M; Hanna LA; Kane JM
    Psychiatr Serv; 2020 Apr; 71(4):337-342. PubMed ID: 31847736
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Converting oral to long-acting injectable antipsychotics: a guide for the perplexed.
    Meyer JM
    CNS Spectr; 2017 Dec; 22(S1):14-28. PubMed ID: 29350127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.